| Patent | Date |
|---|
Use of VHH antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications
Grant 10,174,105 - Rougeon , et al. J | 2019-01-08 |
Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
Grant 10,155,054 - Lafaye , et al. Dec | 2018-12-18 |
Variable Domains Of Camelid Heavy-chain Antibodies Directed Against Glial Fibrillary Acidic Proteins
App 20170165383 - LAFAYE; Pierre ; et al. | 2017-06-15 |
Use Of Vhh Antibodies For The Preparation Of Peptide Vectors For Delivering A Substance Of Interest And Their Applications
App 20170002065 - ROUGEON; Francois ; et al. | 2017-01-05 |
VHH antibodies used as peptide vectors for delivering a substance of interest
Grant 9,387,260 - Rougeon , et al. July 12, 2 | 2016-07-12 |
Variable Domains Of Camelid Heavy-chain Antibodies Directed Against Glial Fibrillary Acidic Proteins
App 20140206081 - Lafaye; Pierre ; et al. | 2014-07-24 |
Use Of Terminal Deoxynucleotidyl Transferase For Mutagenic Dna Repair To Generate Variability, At A Determined Position In Dna
App 20130165347 - Rougeon; Francois ; et al. | 2013-06-27 |
Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
Grant 8,460,888 - Lafaye , et al. June 11, 2 | 2013-06-11 |
Variable Domains Of Camelid Heavy-chain Antibodies Directed Against Glial Fibrillary Acidic Proteins
App 20110250211 - Lafaye; Pierre ; et al. | 2011-10-13 |
Use Of A Camelid Single-domain Antibody For Detecting An Oligomeric Form Of An Amyloid Beta Peptide And Its Applications
App 20100266576 - Rougeon; Francois ; et al. | 2010-10-21 |
Process For Identifying A Ligand That Binds To The Nep Binding Site For The Smr1 Pentapeptide
App 20100041072 - Rougeot; Catherine ; et al. | 2010-02-18 |
Use Of Vhh Antibodies For The Preparation Of Peptide Vectors For Delivering A Substance Of Interest And Their Applications
App 20100021384 - ROUGEON; Francois ; et al. | 2010-01-28 |
Process for identifying a ligand that binds to the NEP binding site for the SMR1 pentapeptide
Grant 7,625,713 - Rougeot , et al. December 1, 2 | 2009-12-01 |
Therapeutic use of the SMR1 protein and active derivatives thereof
Grant 7,429,448 - Rougeot , et al. September 30, 2 | 2008-09-30 |
Treatment of mood disorders by administration of SMR1
Grant 7,423,020 - Rougeot , et al. September 9, 2 | 2008-09-09 |
Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
Grant 7,387,778 - Marcel , et al. June 17, 2 | 2008-06-17 |
Therapeutic uses of SMR1 peptides
App 20070054861 - Rougeot; Catherine ; et al. | 2007-03-08 |
Therapeutic uses of SMR1 peptides
Grant 7,153,833 - Rougeot , et al. December 26, 2 | 2006-12-26 |
Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes
App 20050153374 - Rosinski-Chupin, Isabelle ; et al. | 2005-07-14 |
Therapeutic use of the SMR1 protein and active derivatives thereof
Grant 6,818,405 - Rougeot , et al. November 16, 2 | 2004-11-16 |
Therapeutic uses of smri peptides
App 20040116342 - Rougeot, Catherine ; et al. | 2004-06-17 |
Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
App 20040092486 - Rougeot, Catherine ; et al. | 2004-05-13 |
Therapeutic use of the SMR1 protein and active derivatives thereof
App 20040047805 - Rougeot, Catherine ; et al. | 2004-03-11 |
Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives
App 20030195155 - Rougeot, Catherine ; et al. | 2003-10-16 |
Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
App 20030186870 - Marcel, Tony ; et al. | 2003-10-02 |
Peptides And Polypeptides Derived From The Submaxillary Gland Of The Rat Corresponding Polyclonal And Monoclonal Antibodies Corresponding Hybridomas And Uses Of These Products For Diagnosis For Detection Or Therapeutic Purposes
App 20030170620 - ROSINSKI-CHUPIN, ISABELLE ; et al. | 2003-09-11 |
Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
App 20030078200 - Marcel, Tony ; et al. | 2003-04-24 |
Therapeutic Use Of The Smr 1 Protein And Active Derivatives Thereof
App 20020198361 - ROUGEOT, CATHERINE ; et al. | 2002-12-26 |
Therapeutic Use Of The Smr1 Protein, The Smr1 Maturation Products, Specifically The Qhnpr Pentapeptide As Well As Its Biologically Active Derivatives
App 20020019008 - ROUGEOT, CATHERINE ; et al. | 2002-02-14 |
Antibodies directed against peptides derived from the SMR1 polypeptide
Grant 6,025,143 - Rosinski-Chupin , et al. February 15, 2 | 2000-02-15 |
Method for generating structural and functional diversity in a peptide sequence
Grant 5,756,323 - Kallenbach , et al. May 26, 1 | 1998-05-26 |
| 